Interleukin 10 decreases MICA expression on melanoma cell surface (Q34131549)

31 July 2017

Interleukin 10 decreases MICA expression on melanoma cell surface (English)

1 reference

31 July 2017

Antonio E Serrano

1

1 reference

31 July 2017

Evelyn Menares-Castillo

2

1 reference

31 July 2017

Macarena Garrido-Tapia

3

1 reference

31 July 2017

Carolina Hager Ribeiro

4

1 reference

31 July 2017

Carolina J Hernández

5

1 reference

31 July 2017

Ariadna Mendoza-Naranjo

6

1 reference

31 July 2017

Marcela Gatica-Andrades

7

1 reference

31 July 2017

Rodrigo Valenzuela-Diaz

8

1 reference

31 July 2017

Roberto Zúñiga

9

1 reference

31 July 2017

Mercedes N López

10

1 reference

31 July 2017

Flavio Salazar-Onfray

11

1 reference

31 July 2017

Juan-Carlos Aguillón

12

1 reference

31 July 2017

María-Carmen Molina

13

1 reference

31 July 2017

17 August 2010

1 reference

Immunology & Cell Biology

31 July 2017

1 reference

31 July 2017

89

1 reference

31 July 2017

3

1 reference

31 July 2017

447-457

1 reference

https://scigraph.springernature.com/pub.10.1038/icb.2010.100

31 July 2017

0 references

cites work

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

A second lineage of mammalian major histocompatibility complex class I genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

NKG2D and cytotoxic effector function in tumor immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

NKG2D ligands in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Tumor cell recognition by the NK cell activating receptor NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Tumor-associated MICA is shed by ADAM proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Proteolytic release of soluble UL16-binding protein 2 from tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Opposing effects of interferon-alpha and interferon-gamma on the expression of major histocompatibility complex class I chain-related A in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Interleukin-10: a cytokine used by tumors to escape immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Expression of interleukin 10 in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Increased interleukin-10 serum levels in patients with solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Altered immune responses in interleukin 10 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Regulation of NKG2D ligands: a purposeful but delicate affair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Regulation of NKG2D ligand gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Brief residence at the plasma membrane of the MHC class I-related chain B is due to clathrin-mediated cholesterol-dependent endocytosis and shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and Transporter associated with Antigen Processing 1/2 in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Up on the tightrope: natural killer cell activation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Association of an NKG2D gene variant with systemic lupus erythematosus in two populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

CD107a as a functional marker for the identification of natural killer cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Human NK cell education by inhibitory receptors for MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Crystal structure of Epstein-Barr virus protein BCRF1, a homolog of cellular interleukin-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Targeting STAT3 affects melanoma on multiple fronts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Axis of evil: molecular mechanisms of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

inferred from DOI database lookup

7 January 2021

based on heuristic

IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.100

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ICB.2010.100

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference